The Impact of the Myeloid Response to Radiation Therapy
Open Access
- 7 April 2013
- journal article
- review article
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2013, 1-14
- https://doi.org/10.1155/2013/281958
Abstract
Radiation therapy is showing potential as a partner for immunotherapies in preclinical cancer models and early clinical studies. As has been discussed elsewhere, radiation provides debulking, antigen and adjuvant release, and inflammatory targeting of effector cells to the treatment site, thereby assisting multiple critical checkpoints in antitumor adaptive immunity. Adaptive immunity is terminated by inflammatory resolution, an active process which ensures that inflammatory damage is repaired and tissue function is restored. We discuss how radiation therapy similarly triggers inflammation followed by repair, the consequences to adaptive immune responses in the treatment site, and how the myeloid response to radiation may impact immunotherapies designed to improve control of residual cancer cells.Keywords
This publication has 155 references indexed in Scilit:
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic CancerCancer Cell, 2012
- CD169+ macrophages at the crossroads of antigen presentationTrends in Immunology, 2012
- The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasisCancer Immunology, Immunotherapy, 2011
- Stereotactic Ablative Radiotherapy Should Be Combined With a Hypoxic Cell RadiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiationJournal of Pediatric Surgery, 2010
- Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSFEuropean Journal of Immunology, 2009
- Immunosuppressive CD14+HLA‐DRlow/− monocytes in prostate cancerThe Prostate, 2009
- CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of MacrophagesCancer Cell, 2009
- Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cellsInternational Immunopharmacology, 2009
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008